Changes in brain volume 2 years after extracranial-intracranial bypass surgery: A preliminary subanalysis of the Japanese EC-IC trial

Cerebrovascular Diseases

Volumn 22, Issue 2-3, 2006, Pages 177-182

  Jinnouchi, Juro ^a   Toyoda, Kazunori ^a,c   Inoue, Tooru ^a   Fujimoto, Shigeru ^a   Gotoh, Seiji ^a   Yasumori, Kotaro ^a   Ibayashi, Setsuro ^b   Iida, Mitsuo ^b   Okada, Yasushi ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Brain atrophy; Brain infarction; Cerebral blood flow; Extracranial intracranial bypass surgery; Stroke outcome; Vascular reactivity

Indexed keywords

ACETAZOLAMIDE; CYSTEINE ETHYL ESTER TC 99M; IOFETAMINE I 123; TRACER;

ADULT; AGED; ARTICLE; BRAIN ARTERY BYPASS; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMISPHERE; HEMODYNAMICS; HUMAN; JAPAN; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETAZOLAMIDE; AGED; ATROPHY; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIAL DISEASES; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 33746376958     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093452     Document Type: Article

References (20)

1. Meyer JS, Rauch GM, Crawford K, Rauchi RA, Konno S, Akiyama H, Terayama Y, Haque A: Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 1999;14:1050-1061.
2. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R: Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005;64:1704-1711.
3. Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H: Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002;58:1539-1541.
4. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ: Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 2004;63:2354-2359.
5. Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE 3rd, Brownscheidle CM: A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:139-148.
6. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J: Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol 1997;41:606-614.
7. Kitagawa Y, Meyer JS, Tanahashi N, Rogers RL, Tachibana H, Kandula P, Dowell RE, Mortel KF: Cerebral blood flow and brain atrophy correlated by xenon contrast CT scanning. Comput Radiol 1985;9:331-340.
8. 133Xe inhalation and computerized tomography. J Neurol Neurosurg Psychiatry 1978;41:894-899.
9. Kitani M, Kobayashi S, Yamaguchi S, Okada K: Cerebral atrophy precedes the change in cerebral blood flow in patients with ischemic cerebrovascular disease: a short-term follow-up study. Gerontology 1992;38:1-8.
10. Yamauchi H, Fukuyama H, Nabatame H, Harada K, Kimura J: Callosal atrophy with reduced cortical oxygen metabolism in carotid artery disease. Stroke 1993;24:88-93.
11. Yamauchi H, Pagani M, Fukuyama H, Ouchi Y, Nagahama Y, Matsuzaki S, Kimura J, Yonekura Y, Konishi J: Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxygen metabolism after carotid artery occlusion: a follow-up study with MRI and PET. J Neurol Neurosurg Psychiatry 1995;59:420-426.
12. JET Study Group: Japanese EC-IC Trial (JET Study): study design and interim analysis (in Japanese). Surg Cereb Stroke (Jpn) 2002;30:97-100.
13. Koga H, Yuzuriha T, Yao H, Endo K, Hiejima S, Takashima Y, Sadanaga F, Matsumoto T, Uchino A, Ogomori K, Ichimiya A, Uchimura H, Tashiro N: Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects. J Neurol Neurosurg Psychiatry 2002;72:737-741.
14. Fujimoto S, Toyoda K, Inoue T, Hirai Y, Uwatoko T, Kishikawa K, Yasumori K, Ibayashi S, Iida M, Okada Y: Diagnostic impact of transcranial color-coded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy. Stroke 2004;35:1852-1856.
15. Hirai Y, Fujimoto S, Toyoda K, Inoue T, Uwatoko T, Makihara N, Yasumori K, Ibayashi S, Iida M, Okada Y: Superficial temporal artery duplex ultrasonography for improved cerebral hemodynamics after extracranial- intracranial bypass surgery. Cerebrovasc Dis 2005;20:463-469.
16. Yamauchi H, Fukuyama H, Nagahama Y, Oyanagi C, Okazawa H, Ueno M, Konishi J, Shio H: Long-term changes of hemodynamics and metabolism after carotid artery occlusion. Neurology 2000;54:2095-2102.
17. 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994;14:763-770.
18. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H: Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-2116.
19. Ogasawara K, Ogawa A, Yoshimoto T: Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857-1862.
20. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M: Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood How Metab 2001;21:1472-1479.